Kun for helsepersonell

Viktig sikkerhets-og forskrivningsinformasjon: Breyanzi® (lisocabtagene maraleucel)

image

How to tackle unmet needs in DLBCL?

Interview: 2 minutes

In this interview Professor Sirpa Leppä, Helsinki University Hospital, outlines practical focus areas for the DLBCL working group within the Nordic Lymphoma Group. Listen in to what Prof Leppä shares on high risc populations.

 

Related videos

Biomarkers in LBCL
From Clinical Study To Clinical Practice with CAR-T

News

Learn about current topics in hematology, such as new research data, news from events, congresses and more.

Education

Find past and upcoming educational events and access learning tools such as webinars, training videos and expert interviews.

 

HE-SE-2500027 Feb 2025 video /2009-NO-2500020 Dec 2025